Is Arcadia Biosciences, Inc. (RKDA) a Buy, Sell, or Hold?
Arcadia Biosciences, Inc.
NASDAQ:RKDA
$0.62 USD
$0.0 (-0.74%)
- Volume
- 24.23K
- Average Volume
- 3.09M
- Market Capitalization
- $959.34K
- P/E Ratio
- -0.09
- Dividend Yield
- 0.00%
- Price Target
- $6.00
- Year High
- $6.71
- Year Low
- $0.60
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.79
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Thomas J. Schaefer |
| Industry | Agricultural Inputs |
| Sector | Basic Materials |
| Current Symbol | RKDA |
| CUSIP | 039014303 |
| CIK | 0001469443 |
| Web | https://www.arcadiabio.com |
| Phone | 530 756 7077 |
| Currency | USD |
| Employees | 8 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 0.00 |
| Payout Ratio | 0.00 |
| Current Ratio | 3.79 |
| Quick Ratio | 3.17 |
| Cash Ratio | 0.70 |
Sales & Book Value
| Annual Sales | $4.86M |
| Price / Sales | 0.20 |
| Cash Flow | -3.11 |
| Price / Cash Flow | -0.23 |
| Price / Book | 0.29 |
Price Target and Rating
| Average Stock Price Forecast | $6.00 |
| High Stock Price Forecast | $6.00 |
| Low Stock Price Forecast | $6.00 |
| Forecast Upside/Downside | -89.67% |
| Consensus Rating | Strong Sell |
| Rating Score(0-5) | 1 |
| Research Coverage | 5 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-1.71 |
| Trailing P/E Ratio | -0.09 |
| PEG Ratio | 0.00 |
| P/E Growth | 0.00 |
| Net Income | $-2.34M |
| Net Margin | -195.94% |
| Pretax Margin | -195.78% |
| Return on Equity | -219.35% |
| Return on Assets | -175.15% |
Financials Score
| AltmanZ Score | -78.90 |
| Piotroski Score | 2.00 |
| Working Capital | 3.8M |
| Total Assets | 5.32M |
| Ebit | -9.32M |
| Market Cap | 966.45K |
| Total Liabilities | 2.44M |
Poll Results
About Arcadia Biosciences, Inc. (NASDAQ:RKDA) Stock
Arcadia Biosciences, Inc. is a U.S.-based company that provides plant-derived health and well-being products. Additionally, it is actively engaged in agricultural research and development, with a particular focus on improving wheat crops. The aim of these innovations is to enhance farmers' economic stability by boosting crop performance in the field, increasing their value for food and wellness applications, and expanding their potential for industrial uses. Established in 2002, the company's main office is located in Davis, California. ...
2026-06-12 22:00:00
DALLAS, June 12, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc. (Nasdaq: RKDA), a producer and marketer of innovative wellness products, announced today the closing of its previously announced private placement priced at-the-market under Nasdaq rules for the purchase and sale of 3,883,496 shares of its common stock (or pre-funded warrants in lieu thereof), Series A-1 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock and Series A-2 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock at a purchase price of $1.
2026-06-12 22:00:00
DALLAS, June 12, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, announced today the closing of its previously announced private placement priced at-the-market under Nasdaq rules for the purchase and sale of 3,883,496 shares of its common stock (or pre-funded warrants in lieu thereof), Series A-1 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock and Series A-2 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock at a purchase price of $1.03 per share of common stock (or pre-funded warrant in lieu thereof) and associated preferred investment options.
2026-06-11 20:00:00
DALLAS, June 11, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc. (Nasdaq: RKDA), a producer and marketer of innovative wellness products, announced today that it has entered into securities purchase agreements for the purchase and sale of 3,883,496 shares of its common stock (or pre-funded warrants in lieu thereof), Series A-1 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock and Series A-2 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock at a purchase price of $1.
2026-06-11 20:00:00
DALLAS, June 11, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc .® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, announced today that it has entered into securities purchase agreements for the purchase and sale of 3,883,496 shares of its common stock (or pre-funded warrants in lieu thereof), Series A-1 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock and Series A-2 preferred investment options to purchase up to an aggregate of 3,883,496 shares of common stock at a purchase price of $1.03 per share of common stock (or pre-funded warrant in lieu thereof) and associated preferred investment options in a private placement priced at-the-market under Nasdaq rules.
Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights
2026-05-14 16:05:00
-- Zola ® volumes increase 18% year-over-year -- -- SG&A at lowest level in Arcadia's history -- DALLAS, May 14, 2026 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc .® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today released its financial and business results for the first quarter of 2026.
Frequently Asked Questions
-
What is the current Arcadia Biosciences, Inc. (RKDA) stock price?
-
Arcadia Biosciences, Inc.(NASDAQ:RKDA) stock price is $0.62 in the last trading session. During the trading session, RKDA stock reached the peak price of $6.71 while $0.6 was the lowest point it dropped to. The percentage change in RKDA stock occurred in the recent session was --0.74% while the dollar amount for the price change in RKDA stock was -$-0.0.
-
RKDA's industry and sector of operation?
-
The NASDAQ listed RKDA is part of Agricultural Inputs industry that operates in the broader Basic Materials sector.
-
Who are the executives of RKDA?
-
Thomas J. Schaefer | CEO, Interim CFO, Principal Accounting Officer, President, Corporate Secretary & Director
|
|
|
| -
How many employees does RKDA have?
-
Number of RKDA employees currently stands at 8. RKDA operates from 202 Cousteau Place, Davis, TX 95618, US.
-
Link for RKDA official website?
-
Official Website of RKDA is: https://www.arcadiabio.com
-
How do I contact RKDA?
-
RKDA could be contacted at phone #530 756 7077 and can also be accessed through its website. RKDA operates from 202 Cousteau Place, Davis, TX 95618, US.
-
How many shares of RKDA are traded daily?
-
The average number of RKDA shares traded daily for last 3 months was 3.09M.
-
What is the market cap of RKDA currently?
-
The market value of RKDA currently stands at $959.34K with its latest stock price at $0.62